About: Emicerfont

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Emicerfont (GW-876,008) is a drug developed by GlaxoSmithKline which acts as a CRF-1 antagonist. Corticotropin releasing factor (CRF), also known as Corticotropin releasing hormone, is an endogenous peptide hormone which is released in response to various triggers such as chronic stress, and activates the two corticotropin-releasing hormone receptors: CRF1 and CRF2. This then triggers the release of corticotropin (ACTH), another hormone which is involved in the physiological response to stress.

Property Value
dbo:abstract
  • Emicerfont (GW-876,008) is a drug developed by GlaxoSmithKline which acts as a CRF-1 antagonist. Corticotropin releasing factor (CRF), also known as Corticotropin releasing hormone, is an endogenous peptide hormone which is released in response to various triggers such as chronic stress, and activates the two corticotropin-releasing hormone receptors: CRF1 and CRF2. This then triggers the release of corticotropin (ACTH), another hormone which is involved in the physiological response to stress. Emicerfont blocks the CRF1 receptor, and so reduces ACTH release. It has been investigated for the treatment of irritable bowel syndrome (IBS) and alcoholism, and while it was not effective enough to be adopted for medical use in these applications, it continues to be used for research, as the role of the CRH-ACTH system in IBS remains poorly understood. (en)
dbo:casNumber
  • 786701-13-1
dbo:fdaUniiCode
  • OJ8EG4264P
dbo:kegg
  • D09610
dbo:pubchem
  • 11223423
dbo:thumbnail
dbo:wikiPageID
  • 47504867 (xsd:integer)
dbo:wikiPageLength
  • 3608 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1073190194 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • None (en)
dbp:c
  • 22 (xsd:integer)
dbp:casNumber
  • 786701 (xsd:integer)
dbp:chemspiderid
  • 9398476 (xsd:integer)
dbp:h
  • 24 (xsd:integer)
dbp:iupacName
  • 1 (xsd:integer)
dbp:kegg
  • D09610 (en)
dbp:n
  • 6 (xsd:integer)
dbp:o
  • 2 (xsd:integer)
dbp:pubchem
  • 11223423 (xsd:integer)
dbp:routesOfAdministration
  • Oral (en)
dbp:smiles
  • CC1=CN2CCC3=C2N=CC (en)
dbp:unii
  • OJ8EG4264P (en)
dbp:width
  • 275 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Emicerfont (GW-876,008) is a drug developed by GlaxoSmithKline which acts as a CRF-1 antagonist. Corticotropin releasing factor (CRF), also known as Corticotropin releasing hormone, is an endogenous peptide hormone which is released in response to various triggers such as chronic stress, and activates the two corticotropin-releasing hormone receptors: CRF1 and CRF2. This then triggers the release of corticotropin (ACTH), another hormone which is involved in the physiological response to stress. (en)
rdfs:label
  • Emicerfont (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License